You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Eli Lilly and Company is a multinational, research‑driven pharmaceutical firm that discovers, develops, manufactures and markets prescription medicines and a limited range of animal‑health products. It operates primarily in the healthcare sector, focusing on therapeutic areas such as diabetes and obesity, oncology, immunology and neuroscience. Lilly’s business model relies on a robust pipeline of innovative drugs, extensive clinical development, and global sales through wholesalers, pharmacy benefit managers and hospitals. The company is regarded as one of the world’s largest pharma manufacturers, with a strong market presence in the United States and a growing footprint across more than 120 countries.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q3 FY26 | Oct 29, 2026 | — |
| Q2 FY26 | Aug 5, 2026 | $8.38 |
| Q1 FY26 | Apr 30, 2026 | $8.55 |
| Q4 FY25 | Feb 4, 2026 | $7.54 |
| Q3 FY25 | Oct 30, 2025 | $7.02 |
Stay ahead of LLY earnings
Get reminders ahead of LLY's next earnings report, so you always know when results are coming.